Opposition 91299540
OtherUSPTO
Opposition 91299540 at USPTO between Genzyme Corporation and Kibow Biotech LLC, over the mark RENADYL, filed Jun 7, 2025. Status in the office record: other.
- Status
- Other
- Result
- Other
- Filed
- Jun 7, 2025
- Marks involved
- 2
Parties
Who is involved
The parties as named in the office record.
Opponent
Genzyme Corporation
Respondent
Kibow Biotech LLC
Timeline
How the case has moved
Dates from the USPTO record and the RENADYL filing.
RENADYL filed
Application 98531377 filed at the USPTO.Opposition filed
Genzyme Corporation started opposition 91299540 at USPTO against RENADYL.
Marks
Marks involved
1 contested mark, 1 mark the challenger relies on.
API
Get this data via the API
Every fact on this page comes from the Signa API. Track oppositions and cancellations on any mark with one request.
GET/v1/proceedings/{id}Parties, dates, outcome and every mark in the case
GET/v1/proceedings?trademark_id={trademark_id}Every proceeding on a mark
GET /v1/proceedings/{id}
ID=prc_d88f6c7b-10e1-42fb-9a46-3270303cdab0
curl https://api.signa.so/v1/proceedings/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"Response
{
"id": "prc_d88f6c7b-10e1-42fb-9a46-3270303cdab0",
"object": "proceeding",
"proceeding_type": "opposition",
"proceeding_number": "91299540",
"status": "other",
"office_code": "US",
"filed_date": "2025-06-07",
"parties": [
{
"name": "Genzyme Corporation",
"role": "opponent"
},
{
"name": "Kibow Biotech LLC",
"role": "respondent"
}
]
}